Stocks
Arcturus Therapeutics Holdings (ARCT) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 6.20 | 1.51 | -25.8 | 4.28 | 265.1 | 3.65 | |||
| Changes by years, y/y, % | +207% | -76% | -1 808% | -117% | +6 098% | +190.8% | |||
Arcturus Therapeutics Holdings. Debt/EBITDA
Arcturus Therapeutics Holdings. Debt/EBITDA, changes, %
Arcturus Therapeutics Holdings (ARCT) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| Debt/EBITDA | -15.3 | -7.42 | 3.07 | 3.17 | 2.41 | 3.65 | ||
| Changes by years, y/y, % | -1 448% | -860% | -118% | -118% | -139% | |||
| Changes by quarters, q/q, % | +149% | -51% | -141% | +3% | -24% | |||
